Learn More
Invitrogen™ Phospho-MEF2A (Thr319) Polyclonal Antibody

Description
A suggested positive control for ICC/IF is Hela cells.
Specifications
Specifications
| Antigen | Phospho-MEF2A (Thr319) |
| Applications | Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 |
| Gene | MEF2A |
| Gene Accession No. | Q02078, Q2MJT0, Q60929 |
| Gene Alias | A430079H05Rik; ADCAD1; C5DELq14.3; DEL5q14.3; MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A); MADS box transcription enhancer factor 2, polypeptide C; mef2; Mef2a; MEF2C; myocyte enhancer factor 2a; myocyte enhancer factor 2C; Myocyte-specific enhancer factor 2A; myocyte-specific enhancer factor 2C; RSRFC4; RSRFC9; Serum response factor-like protein 1 |
| Gene Symbols | MEF2A |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.